Dr. Ian Hampson
Advisory Board Member
Dr. Hampson has had over 35 years of experience in cancer research since obtaining his Ph.D. studying the biochemistry of complex carbohydrates at the University of Manchester Paterson Laboratories in 1982. He has Developed the pathology of angiogenesis which was best exemplified by a landmark paper in Science in 1985, “Angiogenesis induced by degradation products of hyaluronic acid”, which now has over 1000 citations. In 1997, he took up his current post of senior lecturer in gynecological oncology at the University of Manchester, was promoted to Reader in 2013, and Chair of Viral Oncology in 2017. He discovered a new use for the HIV drug lopinavir as a treatment for HPV-related cervical dysplasia. Subsequently preclinical work on this indication resulted in a phase 1 clinical trial in Nairobi (Hampson et al. 2016, PloS One).